Patents by Inventor Ervin Epstein

Ervin Epstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170231968
    Abstract: A method for treating pruritus by topically applying a composition comprising a hedgehog inhibitor compound is provided.
    Type: Application
    Filed: February 9, 2017
    Publication date: August 17, 2017
    Inventor: Ervin Epstein
  • Patent number: 8178298
    Abstract: Methods for isolating patched genes, including the mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Decreased expression of patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The patched and hedgehog genes are useful in creating transgenic animal models for these human cancers. The patched nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
    Type: Grant
    Filed: January 11, 2010
    Date of Patent: May 15, 2012
    Assignees: The Regents of the University of California, The Board of Trustees of the Leland Stanford Junior University
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, Jr.
  • Publication number: 20100221724
    Abstract: Methods for isolating patched genes, including the mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Decreased expression of patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The patched and hedgehog genes are useful in creating transgenic animal models for these human cancers. The patched nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
    Type: Application
    Filed: January 11, 2010
    Publication date: September 2, 2010
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, JR.
  • Patent number: 7659371
    Abstract: Methods for isolating patched genes, including the mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Decreased expression of patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The patched and hedgehog genes are useful in creating transgenic animal models for these human cancers. The patched nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: February 9, 2010
    Assignees: The Regents of the University of California, The Board of Trustees of the Leland Stanford Junior University
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, Jr.
  • Patent number: 7465552
    Abstract: Methods for isolating patched genes, including the mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Decreased expression of patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The patched and hedgehog genes are useful in creating transgenic animal models for these human cancers. The patched nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
    Type: Grant
    Filed: April 22, 2003
    Date of Patent: December 16, 2008
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, Jr.
  • Publication number: 20080300167
    Abstract: Methods for isolating patched genes, including the mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Decreased expression of patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The patched and hedgehog genes are useful in creating transgenic animal models for these human cancers. The patched nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like. The DNA is further used as a diagnostic for a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene.
    Type: Application
    Filed: August 20, 2007
    Publication date: December 4, 2008
    Applicants: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, JR.
  • Patent number: 6946257
    Abstract: Methods are provided for identifying agents that decrease hedgehog signal transduction for ameliorating an effect of loss of function of a patched gene in a mammalian cell.
    Type: Grant
    Filed: August 21, 1997
    Date of Patent: September 20, 2005
    Assignees: Regents of the University of California, Board of Trustees of the Leland S. Stanford, Jr. University
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, Jr.
  • Publication number: 20030186309
    Abstract: Methods for isolating patched genes, particularly mammalian patched genes, including the mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Decreased expression of patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The cancers may be familial, having as a component of risk an inherited genetic predisposition, or may be sporadic. The patched and hedgehog genes are useful in creating transgenic animal models for these human cancers. The patched nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated 15 physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like.
    Type: Application
    Filed: April 22, 2003
    Publication date: October 2, 2003
    Applicants: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein
  • Patent number: 6551782
    Abstract: Methods for isolating patched genes, particularly mammalian patched genes, including the mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Decreased expression of patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The cancers may be familial, having as a component of risk an inherited genetic predisposition, or may be sporadic. The patched and hedgehog genes are useful in creating transgenic animal models for these human cancers. The patched nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated 15 physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: April 22, 2003
    Assignees: Stanford University, University of California
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, Jr.
  • Patent number: 6429354
    Abstract: Methods for isolating patched genes, particularly mammalian patched genes, including the mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Decreased expression of patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The cancers may be familial, having as a component of risk an inherited genetic predisposition, or may be sporadic. The patched and hedgehog genes are useful: in creating transgenic animal models for these human cancers. The patched nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated 15 physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: August 6, 2002
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, Jr.
  • Patent number: 6027882
    Abstract: Methods for isolating patched genes, particularly mammalian patched genes, including mouse and human patched genes, as well as invertebrate patched genes and sequences, are provided. Loss-of function of the patched is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. The cancers may be familial, having as a component of risk an inherited genetic predisposition, or may be sporadic. Therefore, methods for using the patched gene as a diagnostic for assessing a genetic predisposition to cancer, and to identify specific cancers having mutations in this gene, are disclosed.
    Type: Grant
    Filed: May 31, 1996
    Date of Patent: February 22, 2000
    Assignee: The Regents of The University of California
    Inventors: Matthew P. Scott, Lisa V. Goodrich, Ronald L. Johnson, Ervin Epstein, Tony Oro
  • Patent number: 5759811
    Abstract: A mutation in the human sonic hedgehog gene is associated with tumorigenesis. A variety of human tumors, including basal cell carcinomas, breast carcinomas, medulloblastomas, etc., have a somatic mutation that results in an amino acid substitution at position 133 ?*his133 SHH!, or in a mutation at position 114. Such mutated genes and fragments thereof, encoded protein, and antibodies specific for the mutated protein are useful in characterizing the phenotype of associated tumors. The mutant protein is useful in drug screening for compositions that antagonize or otherwise modulate HH activity or expression. The encoded protein is also used as a therapeutic, to modulate cell proliferation and differentiation, and treatment of pathological conditions associated with decreased hedgehog signaling.
    Type: Grant
    Filed: November 13, 1996
    Date of Patent: June 2, 1998
    Assignee: The Regents of the University of California
    Inventors: Ervin Epstein, Zhilan Hu, Jeanette Bonifas